IPG Photonics Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IPGP research report →
Range $92 – $120
Price Chart
About the company
Established in 1990 and headquartered in Oxford, Massachusetts, IPG Photonics Corporation is a leading global developer and manufacturer of high-performance fiber, diode, and hybrid fiber-solid state lasers, along with fiber amplifiers. These advanced laser systems are primarily utilized across a wide range of materials processing applications worldwide. The company's extensive product portfolio encompasses a diverse array of laser types, including hybrid fiber-solid state lasers (offering green and UV wavelengths), fiber-pigtailed packaged diodes, fiber-coupled direct diode systems, high-energy pulsed lasers, multi-wavelength and tunable lasers, and single-polarization/single-frequency models.
- CEO
- Mark Milton Gitin
- IPO
- 2006
- Employees
- 4,840
- HQ
- Marlborough, MA, US
Get TickerSpark's AI analysis on IPGP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.49B
- P/E
- 61.08
- Fwd P/E
- 53.63
- PEG
- 1.06
- P/S
- 2.25
- P/B
- 1.16
- EV/EBITDA
- 14.99
- Div Yield
- 0.00%
- Gross Margin
- 38.71%
- Op Margin
- 1.89%
- Net Margin
- 3.65%
- ROE
- 1.89%
- ROIC
- 0.72%
Latest fiscal year · YoY change
- Revenue
- $1.00B+2.7%
- Gross Profit
- $381.46M+12.8%
- Op Income
- $13.10M
- Net Income
- $31.10M+117.1%
- EPS
- $0.73+117.8%
- OCF Growth
- -69.6%
- FCF Growth
- -102.3%
- 52W High
- $155.82
- 52W Low
- $58.01
- 50D MA
- $74.12
- 200D MA
- $99.76
- Beta
- 1.00
- RSI (14)
- 33
- Avg Volume
- 429.10K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
IPG Photonics delivered 15% revenue growth, strong margin performance above guidance, and reaffirmed demand momentum across industrial and advanced solutions, while guiding Q4 below Q3 due to no tariff refund benefit and some China battery moderation.· November 3, 2026
- Q3 revenue was $288 million, up 15% year over year and 3% sequentially, with Industrial Solutions up 12% and Advanced Solutions up 33%.
- Adjusted EPS was $0.61 and adjusted EBITDA was $52 million, both at the top end of expectations and helped by a $5 million tariff refund benefit.
- Gross margin beat the guide: GAAP gross margin was 40.7% and adjusted gross margin was 41%; excluding tariff refunds, management said gross margin was about 39.3%.
- Orders remained healthy with book-to-bill around 1, but management flagged some near-term moderation in battery capacity additions in China.
- Q4 guidance implies a step down from Q3: revenue of $265 million to $295 million, adjusted gross margin of 37% to 40%, and adjusted EPS of $0.30 to $0.60, with no contribution assumed from Lumibird Medical.
Total revenue was $288 million, up 15% year over year and 3% sequentially. GAAP gross margin was 40.7% and adjusted gross margin was 41%; management said tariff refunds added about 170 basis points and $5 million of net benefit in the quarter. GAAP operating income was $21 million, GAAP net income was $20 million, and GAAP EPS was $0.47. Adjusted operating income was $27 million, adjusted net income was $26 million, adjusted EPS was $0.61, and adjusted EBITDA was $52 million. Cash, cash equivalents, and short-term investments were $926 million with no debt, and cash from operations was $46 million. For Q4 2026, the company guided to revenue of $265 million to $295 million, adjusted gross margin of 37% to 40%, adjusted operating expenses of $91 million to $94 million, adjusted EPS of $0.30 to $0.60, and adjusted EBITDA of $33 million to $50 million. Management said guidance does not assume any contribution from Lumibird Medical.
CEO Mark Gitin emphasized that IPG is seeing broad-based adoption of its differentiated laser and photonics solutions, especially in welding, additive manufacturing, semiconductor, defense, and medical. He framed the quarter as proof that the company’s strategy is working: technological leadership, product innovation, operational excellence, and disciplined capital allocation. His tone was constructive and confident, highlighting long-term opportunities in battery manufacturing, data centers, directed energy, and medical, while also announcing an Investor Day for March 2, 2027 to share long-term targets.
CFO Timothy Mammen highlighted the financial outperformance versus guidance, including $288 million in revenue, 40.7% GAAP gross margin, 41% adjusted gross margin, $21 million GAAP operating income, and $52 million adjusted EBITDA. He noted that the quarter benefited from a $5 million tariff refund and that operating expenses were $91 million, below the guidance range, though he expects OpEx to rise modestly as investments continue. He also said cash was $926 million with no debt, operating cash flow improved to $46 million, and CapEx was $17 million in the quarter and $54 million year to date; excluding the German manufacturing investment, he expects CapEx to run at about 5% of revenue going forward.
Analysts focused on the moderation in China battery capacity additions, and management said that softness is a near-term effect that has been factored into Q4 guidance, while longer-term demand in EVs, stationary storage, and data centers remains strong. Questions also centered on defense lumpiness after the Lockheed Crossbow order; management said most of that order shipped in Q3, the rest will ship in Q4, and the broader defense pipeline remains strong with a new SE product extending range and drone coverage. On gross margin, management said the underlying Q3 level excluding tariff refunds was about 39.3% and sees several hundred basis points of longer-term improvement as product mix, diode efficiency, and manufacturing utilization improve in 2027.
The bull case from this call is that IPG is delivering sustained double-digit growth across both core industrial and higher-growth advanced markets, with book-to-bill around 1 and strong demand commentary across most regions. Management also sees multiple longer-term growth engines: semiconductors, medical, defense, and additive manufacturing, plus an enlarged medical platform from Lumibird Medical that is expected to close in Q4.
The main near-term risk is that Q4 revenue and margins are guided below Q3, partly because there is no tariff refund benefit and because management is seeing moderation in China battery capacity additions. Several growth areas are also described as lumpy or early-stage, especially defense, where revenue depends on program timing, and management said the business can be volatile quarter to quarter. Management also acknowledged that some margin expansion initiatives are still gradual and that material improvements may not fully show up until 2027.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 60.3%
- Shares Outstanding
- 42.51M
- Float Shares
- 25.63M
of shares held by institutions
371 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for IPGP, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Ro KhannaHouse · CA17 | Buy | May 5, 22 | Filing → |
| Ro KhannaHouse · CA17 | Sell | May 23, 22 | Filing → |
| Thomas SuozziHouse · NY03 | Buy | Apr 15, 21 | Filing → |
| Thomas SuozziHouse · NY03 | Sell | Jun 3, 21 | Filing → |
| Dean PhillipsHouse · MN03 | Sell | Jan 4, 19 | Filing → |
| Thomas J. RooneyHouse · FL17 | Buy | Sep 20, 18 | Filing → |
| Thomas J. RooneyHouse · FL17 | Buy | Aug 27, 18 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| First Eagle Investment Management, LLC | 3.35M | ▲ 15.41K |
| Blackrock, Inc. | 2.88M | ▲ 33.03K |
| Vanguard Group Inc | 2.80M | ▼ 31.84K |
| Lazard Asset Management LLC | 2.10M | ▲ 670.32K |
| Sumitomo Mitsui Trust Group, Inc. | 2.06M | ▲ 693.57K |
| Dimensional Fund Advisors LP | 1.81M | ▲ 206.94K |
| Vanguard Portfolio Management LLC | 1.70M | ▲ 52.14K |
| Vanguard Capital Management LLC | 1.24M | ▲ 85.11K |
| State Street Corp | 933.07K | ▲ 23.79K |
| Westwood Holdings Group Inc | 897.99K | ▼ 3.55K |
| Neuberger Berman Group LLC | 822.39K | ▼ 154.58K |
| Thrivent Financial For Lutherans | 679.62K | ▲ 673.96K |
Held by 388 ETFs
Biggest fund positions in IPGP by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 2, 26 | Valentin Gapontsev Trust I | sell | 6,020 |
| Nov 3, 26 | Valentin Gapontsev Trust I | sell | 14,632 |
| Oct 2, 26 | IP FIBRE DEVICES LTD | sell | 9,876 |
| Oct 2, 26 | IP FIBRE DEVICES LTD | sell | 5,485 |
| Oct 2, 26 | SCHERBAKOV EUGENE A | sell | 3,048 |
| Sep 1, 26 | Valentin Gapontsev Trust I | sell | 18,091 |
| Sep 2, 26 | Valentin Gapontsev Trust I | sell | 4,591 |
| Sep 2, 26 | Valentin Gapontsev Trust I | sell | 4,715 |
| Aug 26, 26 | PEELER JOHN R | buy | 1,158 |
| Aug 26, 26 | PEELER JOHN R | buy | 1,552 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our IPGP coverage
Recent articles, reports, and earnings notes.

Top Optical Networking Stocks: Our 5 Picks for September 2026
This countdown covers optical components, transceivers, manufacturing services and transport systems across five ways to participate in the AI-infrastructure theme.

Top Photonics Stocks: Our 7 Picks for August 2026 Edition
A countdown of 7 photonics stocks, with the top pick revealed last.

Top Optical Components Stocks: Our 7 Picks for September 2026
A countdown of seven optical components stocks spanning lasers, transceivers, photonics, optical systems, and enabling semiconductor technologies.
Want a deeper read on IPGP?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
International Markets and IPG (IPGP): A Deep Dive for Investors
zacks.com · Nov 9
IPG Photonics: 3 Key Takeaways for Long-Term Investors
fool.com · Nov 4
IPG Photonics Corporation (IPGP) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 3
IPG Photonics Q3 Earnings Call Highlights
marketbeat.com · Nov 3
IPG Photonics (IPGP) Q3 Earnings and Revenues Top Estimates
zacks.com · Nov 3
IPG Photonics Announces Third Quarter 2026 Financial Results
globenewswire.com · Nov 3
First Eagle Global Fund Q3 202 Portfolio Update
seekingalpha.com · Oct 28
First Eagle U.S. Value Fund Q3 2026 Portfolio Review
seekingalpha.com · Oct 26
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.